Business
AVITA Medical Limited Proposed Redomiciliation to the United States of America - Results of Scheme Meeting
VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)-- AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that shareholders today
About this update from Avita Medical, Inc.
[{"type":"text","content":" VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--\nAVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that shareholders today voted in favour of the scheme of arrangement to effect a redomiciliation of the Company and its subsidiaries (Avita Group) from Australia to the United States of America (Scheme), under which AVITA Therapeutics, Inc. (Avita US), a company incorporated in the State of Delaware in the United States of America, will become the parent company of the Avita Group.\n\n\nVoting results of Scheme Meeting\n\n\nIn accordance with ASX Listing Rule 3.13.2 and section 251AA(2) of the Corporations Act 2001 (Cth), the Company advises that the resolution to approve the Scheme (set out in the Notice of Scheme Meeting contained in Appendix F of the Scheme Booklet) was passed on a poll by the requisite majorities of shareholders.\n\n\nThe voting results of the Scheme Meeting are attached to this announcement.\n\n\nNext steps and key dates\n\n\nThe Scheme will not be effective unless and until:\n\n\n\napproval of the Federal Court of Australia (Court) is obtained at the second Court hearing in connection with the Scheme (Second Court Hearing); and\n\n\nthe Court orders have been lodged with the Australian Securities and Investments Commission (ASIC).\n\n\n\nThe Second Court Hearing is scheduled to be held at 9.30am (AEST) on Monday, 22 June 2020. If the Court approves the Scheme, the Company expects to lodge the Court orders with ASIC on Tuesday, 23 June 2020.\n\n\nThe expected timetable for implementation of the Scheme is set out below:\n\n\n\n\nEvent\n\n\n \n\n\n\nIndicative Date\n\n\n\n\n\nSecond Court Hearing\n\n\n \n\n\n\n22 June 2020\n\n\n\n\n\nEffective Date for the Scheme\n\n\nLast day of trading of the Company’s shares on the ASX\n\n\n \n\n\n\n23 June 2020\n\n\n\n\n\nListing of Avita US on the ASX\n\n\n \n\n\nTrading of Avita US Chess Depositary Interests (CDIs) commences on the ASX on a deferred settlement basis\n\n\n \n\n\n\n24 June 2020\n\n\n\n\n\nRecord Date (for determining the entitlements of shareholders of the Company to Avita US shares or Avita US CDIs)\n\n\n \n\n\n\n7.00pm (AEST) on 25 June 2020\n\n\n\n\n\nLast day of trading of the Company’s American Depositary Shares (ADSs) on NASDAQ\n\n\n\n\nLast day of trading of Avita US CDIs on the ASX on a deferred settlement basis\n\n\n...